Gene · 6548
Papers3,457
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,457
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical review of alkalization therapy in cancer treatment. | Front Oncol | 2022 | 36185175 | PubTator, text mining | PubMed |
| Bone marrow-derived naïve B lymphocytes improve heart function after myocardial infarction: a novel cardioprotective mechanism for empagliflozin. | Basic Res Cardiol | 2022 | 36171393 | PubTator, text mining | PubMed |
| The interplay between physical cues and mechanosensitive ion channels in cancer metastasis. | Front Cell Dev Biol | 2022 | 36158191 | PubTator, text mining | PubMed |
| Sodium-glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway. | Front Cardiovasc Med | 2022 | 36148071 | PubTator, text mining | PubMed |
| DPP4 as a Potential Candidate in Cardiovascular Disease. | J Inflamm Res | 2022 | 36147690 | PubTator, text mining | PubMed |
| The dual role of empagliflozin: Cardio renal protection in T2DM patients. | Ann Med Surg (Lond) | 2022 | 36147179 | PubTator, text mining | PubMed |
| From Diabetes Care to Heart Failure Management: A Potential Therapeutic Approach Combining SGLT2 Inhibitors and Plant Extracts. | Nutrients | 2022 | 36145112 | PubTator, text mining | PubMed |
| Novel Regulators of Macropinocytosis-Dependent Growth Revealed by Informer Set Library Screening in Pancreatic Cancer Cells. | Metabolites | 2022 | 36144235 | PubTator, text mining | PubMed |
| The Physiological Function and Potential Role of the Ubiquitous Na+/H+ Exchanger Isoform 8 (NHE8): An Overview Data. | Int J Mol Sci | 2022 | 36142772 | PubTator, text mining | PubMed |
| Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer. | Genes (Basel) | 2022 | 36140753 | PubTator, text mining | PubMed |
| Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein. | Biomedicines | 2022 | 36140169 | PubTator, text mining | PubMed |
| 6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist. | Biomolecules | 2022 | 36139148 | PubTator, text mining | PubMed |
| Progesterone as an Anti-Inflammatory Drug and Immunomodulator: New Aspects in Hormonal Regulation of the Inflammation. | Biomolecules | 2022 | 36139138 | PubTator, text mining | PubMed |
| SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Heart Disease: A Literature Review. | Methodist Debakey Cardiovasc J | 2022 | 36132575 | PubTator, text mining | PubMed |
| Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis. | Sci Transl Med | 2022 | 36130017 | PubTator, text mining | PubMed |
| Molecular mechanisms, physiological roles, and therapeutic implications of ion fluxes in bone cells: Emphasis on the cation-Cl- cotransporters. | J Cell Physiol | 2022 | 36125923 | PubTator, text mining | PubMed |
| miR-342-3p Inhibits Acute Myeloid Leukemia Progression by Targeting SOX12. | Oxid Med Cell Longev | 2022 | 36120594 | PubTator, text mining | PubMed |
| Cost-effectiveness of adding empagliflozin to the standard therapy for Heart Failure with Preserved Ejection Fraction from the perspective of healthcare systems in China. | Front Cardiovasc Med | 2022 | 36119747 | PubTator, text mining | PubMed |
| Solute exchange through gap junctions lessens the adverse effects of inactivating mutations in metabolite-handling genes. | Elife | 2022 | 36107487 | PubTator, text mining | PubMed |
| Tumor acidity: From hallmark of cancer to target of treatment. | Front Oncol | 2022 | 36106097 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6548/papers?page=23